On April 7, 2021 Regen Biopharma, Inc. (“Regen”) entered into an agreement (“Agreement”) with Oncology Pharma, Inc. (“Licensee”)
whereby Regen granted to Licensee an exclusive right and license for the development and commercialization of certain intellectual property ( “License IP”) for the treatment in humans of pancreatic cancer for a term of fifteen years from April 7, 2021.
WCVC Security Details Share Structure Market Value1...............$1,400,504 a/o Nov 19, 2021 Authorized Shares..10,000,000,000 a/o Nov 15, 2021 Outstanding Shares..7,002,518,141 a/o Nov 15, 2021 -Restricted.....................294,560,229 a/o Nov 15, 2021 -Unrestricted.............6,707,957,912 a/o Nov 15, 2021 Held at DTC.............6,651,950,904 a/o Nov 15, 2021 Float............................223,350,198 a/o Nov 07, 2019 Par Value 0.001
RGBP Security Details Share Structure Market Value1...........$94,486,237 a/o Nov 19, 2021 Authorized Shares...4,800,000,000 a/o Nov 01, 2021 Outstanding Shares..4,478,020,719 a/o Nov 01, 2021 Restricted................24,759,990 a/o Nov 01, 2021 Unrestricted............4,453,260,729 a/o Nov 01, 2021 Held at DTC.............4,039,488,338 a/o Nov 01, 2021 Float........213,897,122 a/o Feb 11, 2019 No Par Value
RGBP Security Details Share Structure Market Value1...........$80,550,759 a/o Apr 09, 2021 Authorized Shares...4,800,000,000 a/o Mar 31, 2021 Outstanding Shares..2,934,453,890 a/o Mar 31, 2021 Restricted................150,366,969 a/o Mar 31, 2021 Unrestricted............2,784,086,921 a/o Mar 31, 2021 Held at DTC.............2,722,831,147 a/o Mar 31, 2021 Float........213,897,122 a/o Feb 11, 2019 No Par Value
News 
Market Data 
Discover 
